PharmiWeb.com - Global Pharma News & Resources
13-Sep-2021

Respiratory Devices Market Report Shows Increasing Demand Due to the High Adoption and Changing Consumer Dynamics

Global Respiratory Devices Market

Overview

Some of the most often used respiratory devices are inhalers, nebulizer treatments, oxygen reflectors, positive airway pressure (PAP) devices, motorized ventilators, pulse oximeters, polysomnography devices, and spirometers.

The global respiratory devices market is anticipated to reach US$ 34,178.1 million by the end of 2027, with a value of US$ 16,878.0 million in 2019.

Drivers

During the forecast period, rising air pollution is projected to drive the global respiratory devices market’s development. Air pollution (PM2.5, ozone, and home air pollution) is the sixth largest cause of death globally, according to the Health Effects Institute’s State of Global Air 2019 study.

Get Latest Sample Of Research Report

Opportunities

Players in the global respiratory devices market may anticipate attractive development possibilities if they invest and fund R&D for breathing problems. Peter Weiss AO, an Australian businessman and arts patron, committed US$ 4 million in support for essential lung disease research in February 2020.

Restraints

Critical mistakes in inhalation testing are common in respiratory devices, which is anticipated to stymie market expansion. Inhaler handling errors can have a negative influence on medication delivery and treatment effectiveness. Lack of drug adherence is also estimated to restrict market expansion. When compared to other chronic illnesses, asthma and COPD have poorer adherence rates.

Key Takeaways

The positive airway pressure devices segment of the global respiratory devices market was worth US$ 4,551.5 million in 2018 and is projected to grow at a CAGR of 11.1 percent to US$ 11,814.6 million by 2027. During the forecast period, the segment’s growth will continue to be aided by an increase in product releases.

The portable oxygen concentrators sub segment held the leading position in the oxygen concentrators segment in the global respiratory devices market in 2018, contributing for 66.6 percent share in terms of value, preceded by home oxygen concentrators. Future product releases are anticipated to drive the growth of this category.

In terms of value, the pulse oximeters sector accounted for 12.7 percent of the worldwide respiratory devices market. The pulse oximeters sub-segment is projected to rise as regulatory approvals for pulse oximeters increase. Masimo obtained FDA authorization for their O3 Regional Oximetry product’s newborn application in June 2019.

Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/1299

Market Trends

The global respiratory devices market’s major players are concentrating on the development and introduction of new products. Pulmogine, a mesh nebulizer, was introduced at the 2019 ERS International Congress by HCmed Innovations Co., Inc., a drug-device combination business.

Product recalls are anticipated to stifle market expansion. Teleflex Incorporated issued a global voluntary recall of the COMFORT FLO Humidification System in February 2020, citing the risk of water flooding the section and entering the circuit if an unusual pressure drop is formed between the water bottle and the section all through high-flow oxygen therapy.

Regulation

Europe

  • Medical gas systems need to be CE Certified and Labelled in accordance with Council Directive 93/42 EEC Concerning Medical Devices (Class IIB); 2006/42 EC Machinery Directive; 97/23/EEC Pressure Equipment Directive (PED) and 2006/95/EC, Low Voltage Electrical Equipment Directive (LVD)

  • In Europe, the MOS systems are treated as medical devices and classified as IIB

  • They require a CE mark for legal marketing. However, the CE Marking process will change as Europe’s new Medical Device Regulation (MDR) comes into force in May 2020

  • Implementation, modification, and maintenance of a quality system (usually ISO 13485) that will meet European and other international requirements are further specifications

Key Developments

June 2019: Rapid Oxygen collaborated with the Connecticut Alliance of Boys & Girls Clubs to donate its R15, a portable oxygen cylinder.

February 2020: Medtronic Pharmaceuticals stated that the firm and the Medtronic Foundation are donating about US$ 1.2 million to coronavirus disaster relief globally.

Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1299 

Respiratory Devices Market – Competitive Landscape

Key players functioning in the global prosthetic liners market consists of Masimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed. Inc., Hamilton Medical AG, Medtronic PLC, Koninklijke Philips N.V., Smiths Medical, General Electric Healthcare Limited, Drägerwerk AG & Co. KGaA, and Inogen Inc.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 13-Sep-2021